openPR Logo
Press release

Growth Dynamics on Glaucoma Therapeutics Market 2019-2026| Key Players: Merck, Novartis, Allergan, Bausch + Lomb, Teva Pharmaceuticals, Aerie Pharmaceuticals, Pfizer, Inotek Pharmaceuticals Corporation

06-18-2019 02:35 PM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Growth Dynamics on Glaucoma Therapeutics Market 2019-2026| Key

Rising demand for novel therapeutics among aging population will enable growth in the global glaucoma therapeutics market. Recently Fortune Business Insights has published a report, titled “Glaucoma THERAPEUTICS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026.” According to the report, in 2018 the global glaucoma therapeutics market was worth US$ 6273.5 Mn. However, the global market is anticipated to expand at a CAGR of 6.1% and reach US$ 10,091 Mn by the end of 2026. The report also classifies the global glaucoma therapeutics market on the basis of various segments.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/glaucoma-therapeutics-market-100312

According to the report glaucoma therapeutics market in North America was worth US$ 2405.9 Mn in 2018. The region is expected to dominate the global market during the forecast period 2019-2026. The growth predicted in North America is attribute to its constantly improving healthcare facilities and adoption of recent advances in glaucoma diagnosis, treatment, and medication. These factors also are expected to bode well for the global glaucoma therapeutics market. Meanwhile, the increasing number of glaucoma cases in nations such as China and India is projected to enable growth in Asia Pacific. Additionally, the region is anticipated to progress at a relatively high CAGR.

Introduction
• Research Scope
• Market Segmentation
• Research Methodology
• Definitions and Assumptions

“Public authorities and governments are adoption several initiatives to create awareness about glaucoma and aid in the cure and prevention of glaucoma. This is projected to generate demand in the global glaucoma therapeutics market,” said a lead analyst at Fortune Business Insights.

Key Insights
• Prevalence of Glaucoma bymajor countries
• Recent industry developmentssuch as partnerships, mergers & acquisitions
• Pipeline analysis
• Reimbursement scenario by keycountries
• Regulatory scenario for keycountries

Request Customization of this Report@ https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/glaucoma-therapeutics-market-100312

Prostaglandins to Remain Dominant among Drug Class Through Forecast Period

In terms of drug class, prostaglandins are the most widely used medication. Additionally, in 2018 the prostaglandins segment was dominating the global glaucoma therapeutics market. The segment accounted for 40.2% of the global market in 2018. Prostaglandins are forecast to dominate the global market during the forecast period as well. Higher efficiency to reduce intraocular pressure (IOP) and minimal risk of side effects associated with the drugs are a few factors aiding the expansion of the prostaglandins segment.

In the coming years, the global glaucoma therapeutics market during is forecast to exhibit a steady growth rate. The report finds that factors such as increasing number of glaucoma cases and technological advancements in diagnostic kits will enable the market gain momentum in the coming years. Additionally, recent innovations by market players for glaucoma’s treatment and increasing purchasing power are major factors expected to boost the global market.

However, high cost associated with glaucoma’s medication and treatment is a key factor that may hamper the growth rate in the global glaucoma therapeutics market.

SEGMENTATION
• By Drug Class
• By Disease Indication
• By Distribution Channel
• By Geography

Allergan and Novartis AG, Together Leading the Global Market Since 2018

The global glaucoma therapeutics market is witnessing an influx of new players. Allergan and Novartis AG, are currently leading players in the global market. The companies are involved in manufacturing and marketing of prostaglandin analogues. Among, prostaglandin analogues Lumigan and Travatan are the two most preferred medications for the treatment of glaucoma. Quality production and marketing of these drugs have enabled the organizations establish a stronghold in the global glaucoma therapeutics market. Besides this, other companies operating in the global glaucoma therapeutics market are Pfizer, Inc., Merck & Co., Inc., Bausch & Lomb Incorporated, Teva Pharmaceutical Industry, Aerie Pharmaceuticals, Pfizer, Inc., and Inotek Pharmaceuticals.

In December 2017, Aerie Pharmaceuticals Inc. introduced new eye drops called Rhopressa. The eye drop is specially designed for faster treatment of glaucoma. This may also positively impact the organization’s current position in the market and enable it gain higher share in the global glaucoma therapeutics market.

Know more@:
https://www.fortunebusinessinsights.com/industry-reports/glaucoma-therapeutics-market-100312

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth Dynamics on Glaucoma Therapeutics Market 2019-2026| Key Players: Merck, Novartis, Allergan, Bausch + Lomb, Teva Pharmaceuticals, Aerie Pharmaceuticals, Pfizer, Inotek Pharmaceuticals Corporation here

News-ID: 1779638 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% CAGR During the Forecast Period
Global Bread Maker Market to Reach USD 11.13 Billion by 2032, Driven by a 4.71% …
The global bread maker market size was valued at USD 7.48 billion in 2023 and is expected to be worth USD 7.70 billion in 2024. The market is projected to reach USD 11.13 billion by 2032, recording a CAGR of 4.71% during the forecast period. Bread maker machines enable users to create a diverse range of bread at home cost-effectively. The increasing demand for innovative home appliances and the rising replacement
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Forecast Period.
Streetwear Industry to Reach $637.12 Billion by 2032 at 7.89% CAGR During Foreca …
The global streetwear market size was valued at USD 325.28 billion in 2023. The market is projected to be worth USD 347.14 billion in 2024 and reach USD 637.13 billion by 2032, exhibiting a CAGR of 7.89% during the forecast period. Asia Pacific dominated the streetwear market with a market share of 36.17% in 2023. Fortune Business InsightsTM displays this information in a report titled, "Streetwear Market, 2024-2032." Request a Free Sample
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Companies- Nike, Supreme, Stussy, BAPE
Streetwear Market Size, Share, Analysis, Overview, Demand, Report, 2032 | Compan …
The streetwear market size was valued at USD 325.28 billion in 2023 and is expected to be worth USD 347.14 billion in 2024. The market is projected to reach USD 637.13 billion by 2032, recording a CAGR of 7.89% during the forecast period. Streetwear is youth-inspired clothing that is highly popular among hip-hop enthusiasts and skateboarders. It is popular for its vibrant colors, bold logo graphics, and unconventional designs. Streetwear is
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- L'Oréal S.A.( France), Unilever Plc (U.K.), Coty Inc. (U.S.)
Perfume Market Size, Share, Growth, Demand, Overview, Report, 2032 | Companies- …
The global perfume market size was valued at USD 48.05 billion in 2023 and is projected to grow from USD 50.45 billion in 2024 to USD 77.52 billion by 2032, exhibiting a CAGR of 5.51% during the forecast period. Perfumes are pleasant smelling solutions made by using oils, fragrances, and other ingredients to create a pleasing aroma. Increasing demand for high-quality beauty and grooming products globally is expected to boost the

All 5 Releases


More Releases for Glaucoma

Glaucoma Surgery Devices Market Report 2024 - Glaucoma Surgery Devices Market Si …
"The Business Research Company recently released a comprehensive report on the Global Glaucoma Surgery Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The glaucoma surgery devices
Global Glaucoma Market
According to a new market research report published by Global Market Estimates, the Global Glaucoma Market is projected to grow at a CAGR value of 5.0% from 2023 to 2028. Growing awareness for early diagnosis of glaucoma have gained prominence due to various educational campaigns and screening programs. Early detection allows for timely intervention, leading to better disease management and reducing the risk of vision loss, thus propelling the market growth.
Glaucoma Treatment Market - Safeguarding Sight: Innovating Glaucoma Treatment fo …
Newark, New Castle, USA: The "Glaucoma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Glaucoma Treatment Market: https://www.growthplusreports.com/report/glaucoma-treatment-market/8926 This latest report researches the industry structure, sales, revenue,
Glaucoma Surgical Devices Market By Device Type (Glaucoma Drainage Devices, Impl …
Glaucoma Surgical Devices market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Glaucoma Surgery Devices Market 2016: Glaucoma Systems, Glaucoma Laser Devices
Latest industry research report on Glaucoma surgery devices are used in the glaucoma treating procedure. These procedures include both surgical and laser therapies performed on a patient. The cases of blindness due to glaucoma is on rise across the several countries. Furthermore, the demand for both technologically as well as advanced surgical equipment has resulted in the popularity of glaucoma surgery devices industry, worldwide. Sudden increase in the aging population and